Legalization of Recreational and Medical Marijuana: What We Don't Know

US Department of Health and Human Services. The Health Consequences of Smoking – 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.

Controlled Substances: by CSA Schedule. Drug Enforcement Agency. US Department of Justice. December 2, 2013. http://www.deadiversion.usdoj.gov/schedules/orangebook/e_cs_sched.pdf. Accessed January 27, 2014.

Room R. Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond [published online ahead of print November 3, 2013]. Addiction. doi: 10.1111/add.12355.

Eddy M. Medical marijuana: Review and analysis of federal and state policies (RL33211). CRS Report for Congress. Congressional Research Service. April 2, 2010. https://www.fas.org/sgp/crs/misc/RL33211.pdf. Accessed January 24, 2014.

Lindsey WT , Stewart D , Childress D. Drug interactions between common illicit drugs and prescription therapies. Am J Drug Alcohol Abuse. 2012:38(4):334–343.

Borgelt LM , Franson KL , Nussbaum AM , Wang GS . The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy. 2013;33(2):195–209.

Stout SM , Cimino NM . Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: A systematic review [published online ahead of print October 25, 2013]. Drug Metab Rev.

Grinspoon L. On the pharmaceuticalization of marijuana. Int J Drug Policy. 2001;12:377–383.

Seamon MJ , Fass JA , Maniscalco-Feichtl M , Abu-Shraie NA . Medical marijuana and the developing role of the pharmacist. Am J Health Syst Pharm 2007;64:1037–1044.

Research Monograph Series: Research findings on smoking of abused substances. National Institute of Drug Abuse. 1999. http://archives.drugabuse.gov/pdf/monographs/99.pdf. Accessed January 29, 2014.

Wang T , Collet JP , Shapiro S , Ware MA . Adverse effects of medical cannabinoids: A systematic review. CMAJ. 2008;178(13):1669–1678.

Hashibe M , Straif K , Tashkin DP , Morgenstern H , Greenland S , Zhang ZF . Epidemiologic review of marijuana use and cancer risk. Alcohol. 2005;35:265–275.

Cannabis and Cannabinoids. National Cancer Institute. November 21, 2013. http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page5. Accessed January 27, 2014.

Joshi M , Joshi A , Bartter T. Marijuana and lung disease [published online ahead of print December 30, 2013]. Curr Opin Pulm Med.

Callaghan RC , Allebeck P , Sidorchuk A. Marijuana use and risk of lung cancer: A 40-year cohort study. Cancer Causes Control. 2013;24(10):1811–1820.